Case Study: Melbourne Biotech Company Expands to U.S. via IP-Focused E-2 Visa
Discover how a Melbourne-based life sciences firm successfully navigated the E-2 Treaty Investor Visa process by leveraging its proprietary intellectual property as a primary investment asset...
Read More